VIDEO: There are ‘several areas’ for potential updates to HF guidelines
Click Here to Manage Email Alerts
In this video, Javed Butler, MD, the Patrick H. Lehan Chair in Cardiovascular Research, professor and chairman of the department of medicine, University of Mississippi Medical Center, discusses what changes are needed to HF guidelines.
Butler was a moderator for a featured event discussing potential updates to the HF guidelines at this year’s American Heart Association Scientific Sessions.
“Since the last time the AHA guidelines have been updated, there is a lot of progress that has been made in the field,” Butler said. “So, I would suspect that there are several areas in which the guidelines can proceed.”
He noted that since the last updates were made to HF guidelines, there have been positive trial results on HF with reserved ejection fraction from EMPEROR-Preserved, new data on HF prevention from the FIGARO-DKD and FIDELIO-DKD trials of finerenone (Kerendia, Bayer) among patients with chronic kidney disease and diabetes, and the use of SGLT2 inhibitors for HFrEF.
Butler added that there’s “lots going on the field, and it’ll be interesting to see what the guidelines say.”
Collapse
Butler J, et al. Where should new heart failure guidelines change in 2021? Presented at: American Heart Association Scientific Sessions; Nov. 13-15, 2021 (virtual meeting).
Read more about
Click Here to Manage Email Alerts